Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics

Amanda F Petrik, Erin Keast, Eric S Johnson, David H Smith, Gloria D Coronado, Amanda F Petrik, Erin Keast, Eric S Johnson, David H Smith, Gloria D Coronado

Abstract

Background: Colorectal cancer (CRC) is the 3rd leading cancer killer among men and women in the US. The Strategies and Opportunities to STOP Colon Cancer in Priority Populations (STOP CRC) project aimed to increase CRC screening among patients in Federally Qualified Health Centers (FQHCs) through a mailed fecal immunochemical test (FIT) outreach program. However, rates of completion of the follow-up colonoscopy following an abnormal FIT remain low. We developed a multivariable prediction model using data available in the electronic health record to assess the probability of patients obtaining a colonoscopy following an abnormal FIT test.

Methods: To assess the probability of obtaining a colonoscopy, we used Cox regression to develop a risk prediction model among a retrospective cohort of patients with an abnormal FIT result.

Results: Of 1596 patients with an abnormal FIT result, 556 (34.8%) had a recorded colonoscopy within 6 months. The model shows an adequate separation of patients across risk levels for non-adherence to follow-up colonoscopy (bootstrap-corrected C-statistic > 0.63). The refined model included 8 variables: age, race, insurance, GINI income inequality, long-term anticoagulant use, receipt of a flu vaccine in the past year, frequency of missed clinic appointments, and clinic site. The probability of obtaining a follow-up colonoscopy within 6 months varied across quintiles; patients in the lowest quintile had an estimated 18% chance, whereas patients in the top quintile had a greater than 55% chance of obtaining a follow-up colonoscopy.

Conclusions: Knowing who is unlikely to follow-up on an abnormal FIT test could help identify patients who need an early intervention aimed at completing a follow-up colonoscopy.

Trial registration: This trial was registered at ClinicalTrials.gov ( NCT01742065 ) on December 5, 2012. The protocol is available.

Keywords: Colonoscopy; Colorectal cancer screening; Fecal immunochemical test; Follow-up colonoscopy; Multivariable prediction model; Precision medicine; Predictive analytics.

Conflict of interest statement

The authors declare that they have no competing interests at this time.

Figures

Fig. 1
Fig. 1
Risk Model and Patient Population from STOP CRC
Fig. 2
Fig. 2
Observed and Predicted Probability Colonoscopy Completion

References

    1. Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 2013;173(18):1725–1732.
    1. Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117(8):1745–1754. doi: 10.1002/cncr.25730.
    1. Singal AG, Gupta S, Tiro JA, Skinner CS, McCallister K, Sanders JM, et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer. 2016;122(3):456–463. doi: 10.1002/cncr.29770.
    1. Coronado GD, Burdick T, Petrik A, Kapka T, Retecki S, Green B. Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study. J Gen Pract (Los Angel) 2014;2:1000141.
    1. Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, et al. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health. 2016;41(4):864–870. doi: 10.1007/s10900-016-0165-y.
    1. Martin J, Halm EA, Tiro JA, Merchant Z, Balasubramanian BA, McCallister K, et al. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med. 2017;130(1):93.e1–93.e7. doi: 10.1016/j.amjmed.2016.07.028.
    1. Issaka RB, Singh MH, Oshima SM, Laleau VJ, Rachocki CD, Chen EH, et al. Inadequate utilization of diagnostic colonoscopy following abnormal FIT results in an integrated safety-net system. Am J Gastroenterol. 2017;112(2):375–382. doi: 10.1038/ajg.2016.555.
    1. Yu C, Skootsky S, Grossman M, Garner OB, Betlachin A, Esrailian E, et al. A multi-level fit-based quality improvement initiative to improve colorectal Cancer screening in a managed care population. Clin Transl Gastroenterol. 2018;9(8):177. doi: 10.1038/s41424-018-0046-z.
    1. Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal Cancer screening completion: a randomized clinical trial. JAMA. 2017;318(9):806–815. doi: 10.1001/jama.2017.11389.
    1. Jetelina KK, Yudkin JS, Miller S, Berry E, Lieberman A, Gupta S, et al. Patient-reported barriers to completing a diagnostic colonoscopy following abnormal fecal immunochemical test among uninsured patients. J Gen Intern Med. 2019;34(9):1730–1736. doi: 10.1007/s11606-019-05117-0.
    1. Liss DT, Brown T, Lee JY, Altergott M, Buchanan DR, Newland A, et al. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients. Cancer Causes Control. 2016;27(7):881–887. doi: 10.1007/s10552-016-0763-0.
    1. Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, et al. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer Epidemiol Biomark Prev. 2016;25(2):344–350. doi: 10.1158/1055-9965.EPI-15-0470.
    1. Meester RG, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, et al. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016;14(10):1445–51.e8. doi: 10.1016/j.cgh.2016.05.017.
    1. Lamanna A, Sheaffer H, Guerra C, Kochman M. Colorectal Cancer screening navigation for the underserved: experience of an urban program. Gastroenterol Hepatol (N Y) 2016;12(9):547–551.
    1. Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, et al. Results of nurse navigator follow-up after positive colorectal Cancer screening test: a randomized trial. J Am Board Fam Med. 2014;27(6):789–795. doi: 10.3122/jabfm.2014.06.140125.
    1. Escoffery C, Fernandez ME, Vernon SW, Liang S, Maxwell AE, Allen JD, et al. Patient navigation in a colorectal Cancer screening program. J Public Health Manag Pract. 2015;21(5):433–440. doi: 10.1097/PHH.0000000000000132.
    1. Parikh RB, Kakad M, Bates DW. Integrating predictive analytics into high-value care: the Dawn of precision delivery. JAMA. 2016;315(7):651–652. doi: 10.1001/jama.2015.19417.
    1. Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1. doi: 10.1186/s12916-014-0241-z.
    1. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73. doi: 10.7326/M14-0698.
    1. Coronado GD, Vollmer WM, Petrik A, Taplin SH, Burdick TE, Meenan RT, et al. Strategies and opportunities to STOP Colon Cancer in priority populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014;38(2):344–349. doi: 10.1016/j.cct.2014.06.006.
    1. Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, et al. Race/ethnicity and adoption of a population health management approach to colorectal Cancer screening in a community-based healthcare system. J Gen Intern Med. 2016;31(11):1323–1330. doi: 10.1007/s11606-016-3792-1.
    1. Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol. 2008;167(3):362–368. doi: 10.1093/aje/kwm305.
    1. Harrell F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2001.
    1. Petrik A, Green BB, Vollmer WM, Le T, Bachman B, Keast E, et al. The validation of electronic health Records in Accurately Identifying Patients Eligible for colorectal Cancer screening in safety net clinics. Fam Pract. 2016;33(6):639–643. doi: 10.1093/fampra/cmw065.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa